Elisa Gruppioni
0000-0002-4334-6170
Publication & Citation Trends
Publications
0 total
Erratum: Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations.
Cited by 0
Semantic Scholar
Late Breaking Abstract - Next-generation-sequencing of extracellular vesicles from bronchial washing fluid in advanced lung cancer.
Cited by 0
Semantic Scholar
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD)
Cited by 8
Semantic Scholar
ESR1 analysis of liquid biopsy in breast cancer, one-year routine experience of an Italian clinical referral center
Cited by 0
Semantic Scholar
Evaluation of Microsatellite Instability via High-Resolution Melt Analysis in Colorectal Carcinomas
Cited by 0
Semantic Scholar
STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status. OA
Cited by 18
Semantic Scholar
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations
Cited by 3
Semantic Scholar
Molecular Characterization of Advanced-Stage Melanomas in Clinical Practice Using a Laboratory-Developed Next-Generation Sequencing Panel OA
Cited by 6
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(16)
Cancer Genomics and Diagnostics
(14)
Gastrointestinal Tumor Research and Treatment
(14)
Sarcoma Diagnosis and Treatment
(9)
Chromatin Remodeling and Cancer
(9)
Affiliations
Policlinico S.Orsola-Malpighi
Azienda USL di Bologna
Istituti di Ricovero e Cura a Carattere Scientifico
Creative Research Enterprises (United States)
Imation (United States)